Genital Diseases, Female
Welcome,         Profile    Billing    Logout  
 271 Companies   374 Products   374 Products   160 Mechanisms of Action   34 Trials   5514 News 


«12...5051525354555657585960...110111»
  • ||||||||||  Trial primary completion date:  Closed Vitrification of Oocytes (clinicaltrials.gov) -  Mar 10, 2015   
    P=N/A,  N=604, Recruiting, 
    Trial primary completion date: Mar 2015 --> Sep 2015
  • ||||||||||  Emend intravenous (fosaprepitant) / Merck (MSD), Ono Pharma
    Enrollment change, Trial termination, Trial primary completion date:  Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting (clinicaltrials.gov) -  Mar 10, 2015   
    P4,  N=20, Terminated, 
    N=203 --> 71 | Recruiting --> Terminated | Trial primary completion date: May 2014 --> Mar 2015; recruitment difficulties N=75 --> 20 | Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Mar 2015
  • ||||||||||  glufosfamide (D 19575) / Eleison Pharma
    Enrollment change:  Safety and Efficacy Study of Glufosfamide in Ovarian Cancer (clinicaltrials.gov) -  Mar 10, 2015   
    P2,  N=17, Terminated, 
    Initiation date: Oct 2014 --> Aug 2015 N=45 --> 17
  • ||||||||||  Enrollment closed, Trial primary completion date:  Effect of hCG on Receptivity of the Human Endometrium (clinicaltrials.gov) -  Mar 10, 2015   
    P4,  N=30, Active, not recruiting, 
    N=45 --> 17 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Jan 2016
  • ||||||||||  Ovidrel (choriogonadotropin alfa) / EMD Serono, Vagifem (estradiol) / Novo Nordisk, Estrofem (estradiol oral) / Novo Nordisk
    Trial completion, Enrollment change:  The Luteal Phase After GnRHa Trigger - a Proof of Concept Study (clinicaltrials.gov) -  Mar 10, 2015   
    P4,  N=93, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Jan 2016 Recruiting --> Completed | N=180 --> 93
  • ||||||||||  ganitumab (AMG 479) / Takeda, ImmunityBio
    Trial termination, Trial primary completion date:  Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer (clinicaltrials.gov) -  Mar 7, 2015   
    P2,  N=170, Terminated, 
    Completed --> Terminated; Interim analysis results showed that ixabepilone did not improve survival compared with control chemotherapies. Active, not recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Sep 2013; The steering committee of the TRIO014 study has taken the decision to stop the TRIO014 trial.
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Reproductive Medicine Network Biologic Specimen Repository (clinicaltrials.gov) -  Mar 5, 2015   
    P=N/A,  N=1640, Completed, 
    Active, not recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Sep 2013; The steering committee of the TRIO014 study has taken the decision to stop the TRIO014 trial. Enrolling by invitation --> Completed | N=3682 --> 1640 | Trial primary completion date: Nov 2013 --> Nov 2014
  • ||||||||||  Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
    Enrollment open, IO biomarker:  Evaluation of Long Term Immunity Following HPV Vaccination (clinicaltrials.gov) -  Mar 5, 2015   
    P2/3,  N=200, Recruiting, 
    Enrolling by invitation --> Completed | N=3682 --> 1640 | Trial primary completion date: Nov 2013 --> Nov 2014 Not yet recruiting --> Recruiting
  • ||||||||||  letrozole / Generic mfg., clomifene citrate / Generic mfg.
    Trial completion, Enrollment change:  Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS (clinicaltrials.gov) -  Mar 2, 2015   
    P0,  N=100, Completed, 
    Trial primary completion date: Jul 2015 --> May 2016 Not yet recruiting --> Completed | N=80 --> 100
  • ||||||||||  progesterone / Generic mfg.
    Trial termination:  Duration of GnRH-analogue Downregulation and Pregnancy Rates (clinicaltrials.gov) -  Feb 27, 2015   
    P4,  N=300, Terminated, 
    Not yet recruiting --> Completed | N=80 --> 100 Recruiting --> Terminated
  • ||||||||||  Trial suspension:  LH/HCG Receptor Expression and Retrieval Rates (clinicaltrials.gov) -  Feb 27, 2015   
    P=N/A,  N=100, Suspended, 
    Recruiting --> Terminated Recruiting --> Suspended
  • ||||||||||  aspirin / Generic mfg., pioglitazone / Generic mfg., icosapent ethyl / Generic mfg.
    Trial primary completion date:  Mediators of Abnormal Reproductive Function in Obesity (MARO) (clinicaltrials.gov) -  Feb 24, 2015   
    P0,  N=27, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2013 --> Jan 2018 Trial primary completion date: Mar 2015 --> Sep 2015
  • ||||||||||  Enrollment closed:  WHC+ (Women's Health CoOp PLUS) (clinicaltrials.gov) -  Feb 24, 2015   
    P1,  N=641, Active, not recruiting, 
    Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting
  • ||||||||||  Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
    Enrollment open:  Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin (clinicaltrials.gov) -  Feb 21, 2015   
    P1,  N=28, Recruiting, 
    Not yet recruiting --> Recruiting | Initiation date: Feb 2015 --> Jun 2014 Not yet recruiting --> Recruiting